CAM
ABBV icon

Chesapeake Asset Management’s AbbVie ABBV Stock Holding History

Chesapeake Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5
Closed -$71 – 337
2024
Q1 		$71 Buy
+5
New +$862 ﹤0.01% 321
2023
Q4 		– Sell
-5
Closed -$477 – 380
2023
Q3 		$477 Hold
5
– – ﹤0.01% 405
2023
Q2 		$1.35K Buy
+5
New +$733 ﹤0.01% 369

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Chesapeake Asset Management's ABBV Position: Q2 2026 in Review

Chesapeake Asset Management increased its AbbVie (ABBV) stake by 1.9% in Q2 2026, buying an estimated $23K and bringing the position to 5,763 shares worth $1.45M. The position accounts for 1.11% of the portfolio, ranked #18.

Chesapeake Asset Management first reported a position in ABBV in Q1 2023 and has held it in 14 quarters since. The position peaked at $2.02M in Q3 2023. 4,221 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Chesapeake Asset Management held 5,763 shares of AbbVie worth $1.45M as of Q2 2026.
  • Chesapeake Asset Management bought 107 AbbVie shares in Q2 2026, an estimated $23K.
  • AbbVie made up 1.11% of Chesapeake Asset Management's portfolio in Q2 2026, its #18 holding.
  • Chesapeake Asset Management first reported a position in AbbVie in Q1 2023 and has held it in 14 quarters since.
  • Chesapeake Asset Management's AbbVie position peaked at $2.02M in Q3 2023.
  • 4,221 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Chesapeake Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.